-
1
-
-
80053088189
-
Hepatocellular carcinoma
-
El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127.
-
(2011)
N Engl J Med
, vol.365
, pp. 1118-1127
-
-
El-Serag, H.B.1
-
2
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
3
-
-
0029957259
-
Armed with epidemiologic research, China launches programs to prevent liver cancer
-
Skolnick AA. Armed with epidemiologic research, China launches programs to prevent liver cancer. JAMA 1996; 276: 1458-1459.
-
(1996)
JAMA
, vol.276
, pp. 1458-1459
-
-
Skolnick, A.A.1
-
4
-
-
44649158914
-
Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003
-
Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M, Hijioka T, Katayama K, Yabuuchi I, Yoshihara H, Inoue A, Kato M, Takehara T, Tamura S, Kasahara A, Hayashi N, Tsukuma H. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 2008; 148: 820-826.
-
(2008)
Ann Intern Med
, vol.148
, pp. 820-826
-
-
Tanaka, H.1
Imai, Y.2
Hiramatsu, N.3
Ito, Y.4
Imanaka, K.5
Oshita, M.6
Hijioka, T.7
Katayama, K.8
Yabuuchi, I.9
Yoshihara, H.10
Inoue, A.11
Kato, M.12
Takehara, T.13
Tamura, S.14
Kasahara, A.15
Hayashi, N.16
Tsukuma, H.17
-
5
-
-
0642303165
-
The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
-
El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139: 817-823.
-
(2003)
Ann Intern Med
, vol.139
, pp. 817-823
-
-
El-Serag, H.B.1
Davila, J.A.2
Petersen, N.J.3
McGlynn, K.A.4
-
6
-
-
47249128185
-
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004
-
Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008; 48:137-145.
-
(2008)
Hepatology
, vol.48
, pp. 137-145
-
-
Bosetti, C.1
Levi, F.2
Boffetta, P.3
Lucchini, F.4
Negri, E.5
la Vecchia, C.6
-
7
-
-
34447327216
-
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
-
Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121-124.
-
(2007)
Science
, vol.317
, pp. 121-124
-
-
Naugler, W.E.1
Sakurai, T.2
Kim, S.3
Maeda, S.4
Kim, K.5
Elsharkawy, A.M.6
Karin, M.7
-
8
-
-
79959361853
-
Factors that affect risk for hepatocellular carcinoma and effects of surveillance
-
Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR, Roberts LR. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 2011; 9: 617-623.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 617-623
-
-
Yang, J.D.1
Harmsen, W.S.2
Slettedahl, S.W.3
Chaiteerakij, R.4
Enders, F.T.5
Therneau, T.M.6
Orsini, L.7
Kim, W.R.8
Roberts, L.R.9
-
9
-
-
29944436855
-
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
-
Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
-
(2006)
JAMA
, vol.295
, pp. 65-73
-
-
Chen, C.J.1
Yang, H.I.2
Su, J.3
Jen, C.L.4
You, S.L.5
Lu, S.N.6
Huang, G.T.7
Iloeje, U.H.8
-
10
-
-
77951670101
-
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death
-
Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 2010; 138: 1747-1754.
-
(2010)
Gastroenterology
, vol.138
, pp. 1747-1754
-
-
Chen, J.D.1
Yang, H.I.2
Iloeje, U.H.3
You, S.L.4
Lu, S.N.5
Wang, L.Y.6
Su, J.7
Sun, C.A.8
Liaw, Y.F.9
Chen, C.J.10
-
11
-
-
77951439226
-
Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus
-
Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, Williams J, Livingston SE. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 2010; 51: 1531-1537.
-
(2010)
Hepatology
, vol.51
, pp. 1531-1537
-
-
Simonetti, J.1
Bulkow, L.2
McMahon, B.J.3
Homan, C.4
Snowball, M.5
Negus, S.6
Williams, J.7
Livingston, S.E.8
-
12
-
-
77955306935
-
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
-
Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol 2010; 53: 348-356.
-
(2010)
J Hepatol
, vol.53
, pp. 348-356
-
-
Papatheodoridis, G.V.1
Lampertico, P.2
Manolakopoulos, S.3
Lok, A.4
-
13
-
-
80053085786
-
Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C
-
Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN, Iloeje UH, Chen CJ. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol 2011; 29: 3643-3650.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3643-3650
-
-
Huang, Y.T.1
Jen, C.L.2
Yang, H.I.3
Lee, M.H.4
Su, J.5
Lu, S.N.6
Iloeje, U.H.7
Chen, C.J.8
-
14
-
-
78650253568
-
Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma
-
Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, Therneau TM, Kim B, Roberts LR. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011; 9:64-70.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 64-70
-
-
Yang, J.D.1
Kim, W.R.2
Coelho, R.3
Mettler, T.A.4
Benson, J.T.5
Sanderson, S.O.6
Therneau, T.M.7
Kim, B.8
Roberts, L.R.9
-
15
-
-
33845420396
-
The role of cytokines in hepatocellular carcinoma
-
Budhu A, Wang XW. The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 2006; 80: 1197-1213.
-
(2006)
J Leukoc Biol
, vol.80
, pp. 1197-1213
-
-
Budhu, A.1
Wang, X.W.2
-
16
-
-
59849093175
-
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis Crelated advanced liver disease
-
Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis Crelated advanced liver disease. Gastroenterology 2009; 136:138-148.
-
(2009)
Gastroenterology
, vol.136
, pp. 138-148
-
-
Lok, A.S.1
Seeff, L.B.2
Morgan, T.R.3
di Bisceglie, A.M.4
Sterling, R.K.5
Curto, T.M.6
Everson, G.T.7
Lindsay, K.L.8
Lee, W.M.9
Bonkovsky, H.L.10
Dienstag, J.L.11
Ghany, M.G.12
Morishima, C.13
Goodman, Z.D.14
-
17
-
-
7044264264
-
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study
-
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127: 1372-1380.
-
(2004)
Gastroenterology
, vol.127
, pp. 1372-1380
-
-
Davila, J.A.1
Morgan, R.O.2
Shaib, Y.3
McGlynn, K.A.4
El-Serag, H.B.5
-
18
-
-
79955485187
-
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer
-
McGivern DR, Lemon SM. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 2011; 30: 1969-1983.
-
(2011)
Oncogene
, vol.30
, pp. 1969-1983
-
-
McGivern, D.R.1
Lemon, S.M.2
-
19
-
-
0027243462
-
Risk factors for hepatocellular carcinoma among patients with chronic liver disease
-
Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H. et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-1801.
-
(1993)
N Engl J Med
, vol.328
, pp. 1797-1801
-
-
Tsukuma, H.1
Hiyama, T.2
Tanaka, S.3
Nakao, M.4
Yabuuchi, T.5
Kitamura, T.6
Nakanishi, K.7
Fujimoto, I.8
Inoue, A.9
Yamazaki, H.10
-
20
-
-
0022368621
-
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
-
Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313:1256-1262.
-
(1985)
N Engl J Med
, vol.313
, pp. 1256-1262
-
-
Niederau, C.1
Fischer, R.2
Sonnenberg, A.3
Stremmel, W.4
Trampisch, H.J.5
Strohmeyer, G.6
-
21
-
-
0033973253
-
Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma
-
Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, Trichopoulos D, Stuver SO. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000; 85: 498-502.
-
(2000)
Int J Cancer
, vol.85
, pp. 498-502
-
-
Kuper, H.1
Tzonou, A.2
Kaklamani, E.3
Hsieh, C.C.4
Lagiou, P.5
Adami, H.O.6
Trichopoulos, D.7
Stuver, S.O.8
-
22
-
-
0028350768
-
Alcohol and the liver: 1994 update
-
Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology 1994; 106: 1085-1105.
-
(1994)
Gastroenterology
, vol.106
, pp. 1085-1105
-
-
Lieber, C.S.1
-
23
-
-
0037083159
-
Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women
-
Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, Decarli A, Trevisi P, Ribero ML, Martelli C, Porru S, Nardi G. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002; 155: 323-331.
-
(2002)
Am J Epidemiol
, vol.155
, pp. 323-331
-
-
Donato, F.1
Tagger, A.2
Gelatti, U.3
Parrinello, G.4
Boffetta, P.5
Albertini, A.6
Decarli, A.7
Trevisi, P.8
Ribero, M.L.9
Martelli, C.10
Porru, S.11
Nardi, G.12
-
24
-
-
79960743999
-
Diagnosis and management of alcoholic liver disease
-
McCullough AJ, O'Shea RS, Dasarathy S. Diagnosis and management of alcoholic liver disease. J Dig Dis 2011; 12: 257-262.
-
(2011)
J Dig Dis
, vol.12
, pp. 257-262
-
-
McCullough, A.J.1
O'Shea, R.S.2
Dasarathy, S.3
-
25
-
-
79955033727
-
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma
-
Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, Shima T, Kanbara Y, Saibara T, Mori T, Kawata S, Uto H, Takami S, Sumida Y, Takamura T, Kawanaka M, Okanoue T. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011; 9: 428-433.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 428-433
-
-
Yasui, K.1
Hashimoto, E.2
Komorizono, Y.3
Koike, K.4
Arii, S.5
Imai, Y.6
Shima, T.7
Kanbara, Y.8
Saibara, T.9
Mori, T.10
Kawata, S.11
Uto, H.12
Takami, S.13
Sumida, Y.14
Takamura, T.15
Kawanaka, M.16
Okanoue, T.17
-
26
-
-
0842321807
-
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
-
El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126:460-468.
-
(2004)
Gastroenterology
, vol.126
, pp. 460-468
-
-
El-Serag, H.B.1
Tran, T.2
Everhart, J.E.3
-
27
-
-
79960747094
-
Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-Medicare database
-
Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 2011; 54: 463-471.
-
(2011)
Hepatology
, vol.54
, pp. 463-471
-
-
Welzel, T.M.1
Graubard, B.I.2
Zeuzem, S.3
El-Serag, H.B.4
Davila, J.A.5
McGlynn, K.A.6
-
28
-
-
27844432603
-
AKT signaling in normal and malignant cells
-
Testa JR, Tsichlis PN. AKT signaling in normal and malignant cells. Oncogene 2005; 24: 7391-7393.
-
(2005)
Oncogene
, vol.24
, pp. 7391-7393
-
-
Testa, J.R.1
Tsichlis, P.N.2
-
29
-
-
84857184141
-
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance
-
Hafsi S, Pezzino FM, Candido S, Ligresti G, Spandidos DA, Soua Z, McCubrey JA, Travali S, Libra M. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance. Int J Oncol 2012; 40: 639-644.
-
(2012)
Int J Oncol
, vol.40
, pp. 639-644
-
-
Hafsi, S.1
Pezzino, F.M.2
Candido, S.3
Ligresti, G.4
Spandidos, D.A.5
Soua, Z.6
McCubrey, J.A.7
Travali, S.8
Libra, M.9
-
30
-
-
68949190853
-
MicroRNAs involved in tumor suppressor and oncogene pathways: Implications for hepatobiliary neoplasia
-
Mott JL. MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia. Hepatology 2009; 50: 630-637.
-
(2009)
Hepatology
, vol.50
, pp. 630-637
-
-
Mott, J.L.1
-
31
-
-
65949091346
-
Targeting mTOR in renal cell carcinoma
-
Hudes GR. Targeting mTOR in renal cell carcinoma. Cancer 2009; 115: 2313-2320.
-
(2009)
Cancer
, vol.115
, pp. 2313-2320
-
-
Hudes, G.R.1
-
32
-
-
79955110863
-
Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance
-
Sze KM, Wong KL, Chu GK, Lee JM, Yau TO, Ng IO. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology 2011; 53: 1558-1569.
-
(2011)
Hepatology
, vol.53
, pp. 1558-1569
-
-
Sze, K.M.1
Wong, K.L.2
Chu, G.K.3
Lee, J.M.4
Yau, T.O.5
Ng, I.O.6
-
33
-
-
59149105815
-
Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9
-
Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J, Zhang LJ. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res 2009; 39: 177-186.
-
(2009)
Hepatol Res
, vol.39
, pp. 177-186
-
-
Chen, J.S.1
Wang, Q.2
Fu, X.H.3
Huang, X.H.4
Chen, X.L.5
Cao, L.Q.6
Chen, L.Z.7
Tan, H.X.8
Li, W.9
Bi, J.10
Zhang, L.J.11
-
34
-
-
0034255634
-
Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta
-
Mori Y, Chen SJ, Varga J. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Exp Cell Res 2000; 258: 374-383.
-
(2000)
Exp Cell Res
, vol.258
, pp. 374-383
-
-
Mori, Y.1
Chen, S.J.2
Varga, J.3
-
35
-
-
84862798754
-
Transforming growth factor Beta 1 overexpression is closely related to invasiveness of hepatocellular carcinoma
-
Lee D, Chung YH, Kim JA, Lee YS, Jang MK, Kim KM, Lim YS, Lee HC. Transforming growth factor Beta 1 overexpression is closely related to invasiveness of hepatocellular carcinoma. Oncology 2012; 82: 11-18.
-
(2012)
Oncology
, vol.82
, pp. 11-18
-
-
Lee, D.1
Chung, Y.H.2
Kim, J.A.3
Lee, Y.S.4
Jang, M.K.5
Kim, K.M.6
Lim, Y.S.7
Lee, H.C.8
-
36
-
-
84856338151
-
Regulation of gene transcription by the oncoprotein MYC
-
Luscher B, Vervoorts J. Regulation of gene transcription by the oncoprotein MYC. Gene 2012; 494: 145-160.
-
(2012)
Gene
, vol.494
, pp. 145-160
-
-
Luscher, B.1
Vervoorts, J.2
-
37
-
-
0036890030
-
Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray
-
Wang Y, Wu MC, Sham JS, Zhang W, Wu WQ, Guan XY. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 2002; 95: 2346-2352.
-
(2002)
Cancer
, vol.95
, pp. 2346-2352
-
-
Wang, Y.1
Wu, M.C.2
Sham, J.S.3
Zhang, W.4
Wu, W.Q.5
Guan, X.Y.6
-
38
-
-
7744220635
-
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
-
Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Felsher DW. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431: 1112-1117.
-
(2004)
Nature
, vol.431
, pp. 1112-1117
-
-
Shachaf, C.M.1
Kopelman, A.M.2
Arvanitis, C.3
Karlsson, A.4
Beer, S.5
Mandl, S.6
Bachmann, M.H.7
Borowsky, A.D.8
Ruebner, B.9
Cardiff, R.D.10
Yang, Q.11
Bishop, J.M.12
Contag, C.H.13
Felsher, D.W.14
-
39
-
-
0027245446
-
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis
-
Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 1993; 53: 1719-1723.
-
(1993)
Cancer Res
, vol.53
, pp. 1719-1723
-
-
Murakami, H.1
Sanderson, N.D.2
Nagy, P.3
Marino, P.A.4
Merlino, G.5
Thorgeirsson, S.S.6
-
40
-
-
69249230769
-
Mammalian cell-cycle regulation: Several Cdks, numerous cyclins and diverse compensatory mechanisms
-
Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009; 28: 2925-2939.
-
(2009)
Oncogene
, vol.28
, pp. 2925-2939
-
-
Satyanarayana, A.1
Kaldis, P.2
-
41
-
-
84861580616
-
Cyclin G1-mediated epithelial-mesenchymal transition via PI3-K/Akt signaling facilitates liver cancer progression
-
Wen W, Ding J, Sun W, Fu J, Chen Y, Wu K, Ning B, Han T, Huang L, Chen C, Xie D, Li Z, Feng G, Wu M, Xie W, Wang H. Cyclin G1-mediated epithelial-mesenchymal transition via PI3-K/Akt signaling facilitates liver cancer progression. Hepatology 2012; 55: 1787-1798.
-
(2012)
Hepatology
, vol.55
, pp. 1787-1798
-
-
Wen, W.1
Ding, J.2
Sun, W.3
Fu, J.4
Chen, Y.5
Wu, K.6
Ning, B.7
Han, T.8
Huang, L.9
Chen, C.10
Xie, D.11
Li, Z.12
Feng, G.13
Wu, M.14
Xie, W.15
Wang, H.16
-
42
-
-
34250020201
-
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
-
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
-
(2007)
Gastroenterology
, vol.132
, pp. 2557-2576
-
-
El-Serag, H.B.1
Rudolph, K.L.2
-
43
-
-
0034632717
-
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
-
Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406: 641-645.
-
(2000)
Nature
, vol.406
, pp. 641-645
-
-
Artandi, S.E.1
Chang, S.2
Lee, S.L.3
Alson, S.4
Gottlieb, G.J.5
Chin, L.6
DePinho, R.A.7
-
44
-
-
34247400156
-
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis
-
Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH, Wilkens L, Destro A, Fiamengo B, Manns MP, Roncalli M, Rudolph KL. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 2007; 45: 968-976.
-
(2007)
Hepatology
, vol.45
, pp. 968-976
-
-
Plentz, R.R.1
Park, Y.N.2
Lechel, A.3
Kim, H.4
Nellessen, F.5
Langkopf, B.H.6
Wilkens, L.7
Destro, A.8
Fiamengo, B.9
Manns, M.P.10
Roncalli, M.11
Rudolph, K.L.12
-
45
-
-
17844387825
-
Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas
-
Azechi H, Nishida N, Fukuda Y, Nishimura T, Minata M, Katsuma H, Kuno M, Ito T, Komeda T, Kita R, Takahashi R, Nakao K. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 2001; 60: 346-354.
-
(2001)
Oncology
, vol.60
, pp. 346-354
-
-
Azechi, H.1
Nishida, N.2
Fukuda, Y.3
Nishimura, T.4
Minata, M.5
Katsuma, H.6
Kuno, M.7
Ito, T.8
Komeda, T.9
Kita, R.10
Takahashi, R.11
Nakao, K.12
-
46
-
-
23844556529
-
Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16
-
Matsuda Y, Yamagiwa S, Takamura M, Honda Y, Ishimoto Y, Ichida T, Aoyagi Y. Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16. Cancer 2005; 104: 1037-1044.
-
(2005)
Cancer
, vol.104
, pp. 1037-1044
-
-
Matsuda, Y.1
Yamagiwa, S.2
Takamura, M.3
Honda, Y.4
Ishimoto, Y.5
Ichida, T.6
Aoyagi, Y.7
-
47
-
-
80051761743
-
The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
-
Kelly PN, Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 2011; 18: 1414-1424.
-
(2011)
Cell Death Differ
, vol.18
, pp. 1414-1424
-
-
Kelly, P.N.1
Strasser, A.2
-
48
-
-
77955747733
-
BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma
-
Galmiche A, Ezzoukhry Z, Francois C, Louandre C, Sabbagh C, Nguyen-Khac E, Descamps V, Trouillet N, Godin C, Regimbeau JM, Joly JP, Barbare JC, Duverlie G, Maziere JC, Chatelain D. BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma. Mol Cancer Res 2010; 8: 1116-1125.
-
(2010)
Mol Cancer Res
, vol.8
, pp. 1116-1125
-
-
Galmiche, A.1
Ezzoukhry, Z.2
Francois, C.3
Louandre, C.4
Sabbagh, C.5
Nguyen-Khac, E.6
Descamps, V.7
Trouillet, N.8
Godin, C.9
Regimbeau, J.M.10
Joly, J.P.11
Barbare, J.C.12
Duverlie, G.13
Maziere, J.C.14
Chatelain, D.15
-
49
-
-
0035395236
-
beta-Catenin mutation and overexpression in hepatocellular carcinoma: Clinicopathologic and prognostic significance
-
Wong CM, Fan ST, Ng IO. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 2001; 92: 136-145.
-
(2001)
Cancer
, vol.92
, pp. 136-145
-
-
Wong, C.M.1
Fan, S.T.2
Ng, I.O.3
-
50
-
-
34249028607
-
PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression
-
Fischer AN, Fuchs E, Mikula M, Huber H, Beug H, Mikulits W. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene 2007; 26: 3395-3405.
-
(2007)
Oncogene
, vol.26
, pp. 3395-3405
-
-
Fischer, A.N.1
Fuchs, E.2
Mikula, M.3
Huber, H.4
Beug, H.5
Mikulits, W.6
-
51
-
-
84856191525
-
Dysregulation of Wnt/betacatenin signaling in gastrointestinal cancers
-
White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/betacatenin signaling in gastrointestinal cancers. Gastroenterology 2012; 142: 219-232.
-
(2012)
Gastroenterology
, vol.142
, pp. 219-232
-
-
White, B.D.1
Chien, A.J.2
Dawson, D.W.3
-
52
-
-
33749161559
-
Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma
-
Schuierer MM, Bataille F, Weiss TS, Hellerbrand C, Bosserhoff AK. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 2006; 16: 451-456.
-
(2006)
Oncol Rep
, vol.16
, pp. 451-456
-
-
Schuierer, M.M.1
Bataille, F.2
Weiss, T.S.3
Hellerbrand, C.4
Bosserhoff, A.K.5
-
53
-
-
70350212686
-
Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4
-
Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, Fabregat I. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res 2009; 69: 7595-7602.
-
(2009)
Cancer Res
, vol.69
, pp. 7595-7602
-
-
Caja, L.1
Sancho, P.2
Bertran, E.3
Iglesias-Serret, D.4
Gil, J.5
Fabregat, I.6
-
54
-
-
84863158653
-
Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway
-
Zhang Q, Gong R, Qu J, Zhou Y, Liu W, Chen M, Liu Y, Zhu Y, Wu J. Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway. J Virol 2012; 86: 1544-1554.
-
(2012)
J Virol
, vol.86
, pp. 1544-1554
-
-
Zhang, Q.1
Gong, R.2
Qu, J.3
Zhou, Y.4
Liu, W.5
Chen, M.6
Liu, Y.7
Zhu, Y.8
Wu, J.9
-
55
-
-
84860630975
-
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
-
Sansone P, Bromberg J. Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies. J Clin Oncol 2012; 30: 1005-14.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1005-1014
-
-
Sansone, P.1
Bromberg, J.2
-
57
-
-
34047250349
-
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells
-
Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania F. A. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 2007; 67: 2497-2507.
-
(2007)
Cancer Res
, vol.67
, pp. 2497-2507
-
-
Saxena, N.K.1
Sharma, D.2
Ding, X.3
Lin, S.4
Marra, F.5
Merlin, D.6
Anania, F.A.7
-
58
-
-
58249088751
-
MicroRNAs: Target recognition and regulatory functions
-
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
-
(2009)
Cell
, vol.136
, pp. 215-233
-
-
Bartel, D.P.1
-
59
-
-
79951648906
-
Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma
-
Law PT, Wong N. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 2011; 26: 437-449.
-
(2011)
J Gastroenterol Hepatol
, vol.26
, pp. 437-449
-
-
Law, P.T.1
Wong, N.2
-
61
-
-
83255162659
-
An HNF4alphamicroRNA inflammatory feedback circuit regulates hepatocellular oncogenesis
-
Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, Iliopoulos D. An HNF4alphamicroRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011; 147: 1233-1247.
-
(2011)
Cell
, vol.147
, pp. 1233-1247
-
-
Hatziapostolou, M.1
Polytarchou, C.2
Aggelidou, E.3
Drakaki, A.4
Poultsides, G.A.5
Jaeger, S.A.6
Ogata, H.7
Karin, M.8
Struhl, K.9
Hadzopoulou-Cladaras, M.10
Iliopoulos, D.11
-
62
-
-
70349871321
-
MicroRNA expression, survival, and response to interferon in liver cancer
-
Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361: 1437-1447.
-
(2009)
N Engl J Med
, vol.361
, pp. 1437-1447
-
-
Ji, J.1
Shi, J.2
Budhu, A.3
Yu, Z.4
Forgues, M.5
Roessler, S.6
Ambs, S.7
Chen, Y.8
Meltzer, P.S.9
Croce, C.M.10
Qin, L.X.11
Man, K.12
Lo, C.M.13
Lee, J.14
Ng, I.O.15
Fan, J.16
Tang, Z.Y.17
Sun, H.C.18
Wang, X.W.19
-
63
-
-
76249128792
-
miR-221 overexpression contributes to liver tumorigenesis
-
Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 2010; 107: 264-269.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 264-269
-
-
Pineau, P.1
Volinia, S.2
McJunkin, K.3
Marchio, A.4
Battiston, C.5
Terris, B.6
Mazzaferro, V.7
Lowe, S.W.8
Croce, C.M.9
Dejean, A.10
-
65
-
-
14144255291
-
Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs
-
Uprichard SL, Boyd B, Althage A, Chisari FV. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci U S A 2005; 102: 773-778.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 773-778
-
-
Uprichard, S.L.1
Boyd, B.2
Althage, A.3
Chisari, F.V.4
-
66
-
-
80052102854
-
Hepatitis B virus and hepatocellular carcinoma at the miRNA level
-
Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW, Huang AL, Liang Z. Hepatitis B virus and hepatocellular carcinoma at the miRNA level. World J Gastroenterol 2011; 17: 3353-3358.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 3353-3358
-
-
Zhang, Z.Z.1
Liu, X.2
Wang, D.Q.3
Teng, M.K.4
Niu, L.W.5
Huang, A.L.6
Liang, Z.7
-
67
-
-
77954234485
-
Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1
-
Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010; 52:60-70.
-
(2010)
Hepatology
, vol.52
, pp. 60-70
-
-
Huang, J.1
Wang, Y.2
Guo, Y.3
Sun, S.4
-
68
-
-
77955425193
-
miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV
-
Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, Meng S. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 2010; 398: 771-777.
-
(2010)
Biochem Biophys Res Commun
, vol.398
, pp. 771-777
-
-
Qiu, L.1
Fan, H.2
Jin, W.3
Zhao, B.4
Wang, Y.5
Ju, Y.6
Chen, L.7
Chen, Y.8
Duan, Z.9
Meng, S.10
-
70
-
-
59349098653
-
Regulation of the hepatitis C virus genome replication by miR-199a
-
Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 2009; 50: 453-460.
-
(2009)
J Hepatol
, vol.50
, pp. 453-460
-
-
Murakami, Y.1
Aly, H.H.2
Tajima, A.3
Inoue, I.4
Shimotohno, K.5
-
71
-
-
77951460055
-
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins
-
Hou W, Tian Q, Zheng J, Bonkovsky HL. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology 2010; 51: 1494-1504.
-
(2010)
Hepatology
, vol.51
, pp. 1494-1504
-
-
Hou, W.1
Tian, Q.2
Zheng, J.3
Bonkovsky, H.L.4
-
72
-
-
42249089850
-
MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma
-
Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47: 1223-1232.
-
(2008)
Hepatology
, vol.47
, pp. 1223-1232
-
-
Varnholt, H.1
Drebber, U.2
Schulze, F.3
Wedemeyer, I.4
Schirmacher, P.5
Dienes, H.P.6
Odenthal, M.7
-
73
-
-
80051781560
-
Alterations in microRNA expression profile in HCV-infected hepatoma cells: Involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway
-
Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway. Biochem Biophys Res Commun 2011; 412: 92-97.
-
(2011)
Biochem Biophys Res Commun
, vol.412
, pp. 92-97
-
-
Ishida, H.1
Tatsumi, T.2
Hosui, A.3
Nawa, T.4
Kodama, T.5
Shimizu, S.6
Hikita, H.7
Hiramatsu, N.8
Kanto, T.9
Hayashi, N.10
Takehara, T.11
-
74
-
-
65549144017
-
MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity
-
Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009; 58: 1050-1057.
-
(2009)
Diabetes
, vol.58
, pp. 1050-1057
-
-
Xie, H.1
Lim, B.2
Lodish, H.F.3
-
75
-
-
77955992756
-
STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer
-
Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39: 493-506.
-
(2010)
Mol Cell
, vol.39
, pp. 493-506
-
-
Iliopoulos, D.1
Jaeger, S.A.2
Hirsch, H.A.3
Bulyk, M.L.4
Struhl, K.5
-
76
-
-
58149386462
-
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
-
Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, Kellum JM, Min H, Luketic VA, Sanyal AJ. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008; 48: 1810-1820.
-
(2008)
Hepatology
, vol.48
, pp. 1810-1820
-
-
Cheung, O.1
Puri, P.2
Eicken, C.3
Contos, M.J.4
Mirshahi, F.5
Maher, J.W.6
Kellum, J.M.7
Min, H.8
Luketic, V.A.9
Sanyal, A.J.10
-
77
-
-
77952707662
-
MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism
-
Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010; 51: 1513-1523.
-
(2010)
J Lipid Res
, vol.51
, pp. 1513-1523
-
-
Iliopoulos, D.1
Drosatos, K.2
Hiyama, Y.3
Goldberg, I.J.4
Zannis, V.I.5
-
78
-
-
80555150535
-
High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis
-
Ahn J, Lee H, Chung CH, Ha T. High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis. Biochem Biophys Res Commun 2011; 414: 664-669.
-
(2011)
Biochem Biophys Res Commun
, vol.414
, pp. 664-669
-
-
Ahn, J.1
Lee, H.2
Chung, C.H.3
Ha, T.4
-
79
-
-
73449136157
-
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD
-
Zheng L, Lv GC, Sheng J, Yang YD. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol 2010; 25: 156-163.
-
(2010)
J Gastroenterol Hepatol
, vol.25
, pp. 156-163
-
-
Zheng, L.1
Lv, G.C.2
Sheng, J.3
Yang, Y.D.4
-
80
-
-
78651399501
-
Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease
-
Bala S, Marcos M, Kodys K, Csak T, Catalano D, Mandrekar P, Szabo G. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 2011; 286: 1436-1444.
-
(2011)
J Biol Chem
, vol.286
, pp. 1436-1444
-
-
Bala, S.1
Marcos, M.2
Kodys, K.3
Csak, T.4
Catalano, D.5
Mandrekar, P.6
Szabo, G.7
-
81
-
-
38349109046
-
Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease
-
Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, Zhang LJ, Keshavarzian A. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 2008; 32: 355-364.
-
(2008)
Alcohol Clin Exp Res
, vol.32
, pp. 355-364
-
-
Tang, Y.1
Banan, A.2
Forsyth, C.B.3
Fields, J.Z.4
Lau, C.K.5
Zhang, L.J.6
Keshavarzian, A.7
-
82
-
-
67449102314
-
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma
-
Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG, Tan TM. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100: 1234-1242.
-
(2009)
Cancer Sci
, vol.100
, pp. 1234-1242
-
-
Li, Y.1
Tan, W.2
Neo, T.W.3
Aung, M.O.4
Wasser, S.5
Lim, S.G.6
Tan, T.M.7
-
83
-
-
84984539125
-
MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells
-
Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009; 136: 683-693.
-
(2009)
Gastroenterology
, vol.136
, pp. 683-693
-
-
Liu, W.H.1
Yeh, S.H.2
Lu, C.C.3
Yu, S.L.4
Chen, H.Y.5
Lin, C.Y.6
Chen, D.S.7
Chen, P.J.8
-
84
-
-
33144490646
-
A microRNA expression signature of human solid tumors defines cancer gene targets
-
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257-2261.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 2257-2261
-
-
Volinia, S.1
Calin, G.A.2
Liu, C.G.3
Ambs, S.4
Cimmino, A.5
Petrocca, F.6
Visone, R.7
Iorio, M.8
Roldo, C.9
Ferracin, M.10
Prueitt, R.L.11
Yanaihara, N.12
Lanza, G.13
Scarpa, A.14
Vecchione, A.15
Negrini, M.16
Harris, C.C.17
Croce, C.M.18
-
85
-
-
51349165812
-
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype
-
Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T, Rogler CE. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 2008, 173: 856-864.
-
(2008)
Am J Pathol
, vol.173
, pp. 856-864
-
-
Connolly, E.1
Melegari, M.2
Landgraf, P.3
Tchaikovskaya, T.4
Tennant, B.C.5
Slagle, B.L.6
Rogler, L.E.7
Zavolan, M.8
Tuschl, T.9
Rogler, C.E.10
-
86
-
-
34547524771
-
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
-
Meng F, Henson R, Wehbe-Janek H, Ghosha K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658.
-
(2007)
Gastroenterology
, vol.133
, pp. 647-658
-
-
Meng, F.1
Henson, R.2
Wehbe-Janek, H.3
Ghosha, K.4
Jacob, S.T.5
Patel, T.6
-
87
-
-
54249136806
-
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells
-
Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008; 68: 8164-8172.
-
(2008)
Cancer Res
, vol.68
, pp. 8164-8172
-
-
Papagiannakopoulos, T.1
Shapiro, A.2
Kosik, K.S.3
-
88
-
-
75849132381
-
Systematic identification of microRNA and messenger RNA profiles in hepatitis C virusinfected human hepatoma cells
-
Liu X, Wang T, Wakita T, Yang W. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virusinfected human hepatoma cells. Virology 2010; 398: 57-67.
-
(2010)
Virology
, vol.398
, pp. 57-67
-
-
Liu, X.1
Wang, T.2
Wakita, T.3
Yang, W.4
-
89
-
-
41149101523
-
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression
-
Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson AL, Linsley PS, Cleary MA. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28: 2167-2174.
-
(2008)
Mol Cell Biol
, vol.28
, pp. 2167-2174
-
-
Ivanovska, I.1
Ball, A.S.2
Diaz, R.L.3
Magnus, J.F.4
Kibukawa, M.5
Schelter, J.M.6
Kobayashi, S.V.7
Lim, L.8
Burchard, J.9
Jackson, A.L.10
Linsley, P.S.11
Cleary, M.A.12
-
90
-
-
54249158400
-
Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling
-
Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 2008; 68: 8191-8194.
-
(2008)
Cancer Res
, vol.68
, pp. 8191-8194
-
-
Petrocca, F.1
Vecchione, A.2
Croce, C.M.3
-
91
-
-
77950622025
-
MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma
-
Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y, Yan M, Ge C, Zhang Z, Chen T, Wan D, Yao M, Li J, Gu J, He X. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 2010; 51: 846-856.
-
(2010)
Hepatology
, vol.51
, pp. 846-856
-
-
Yao, J.1
Liang, L.2
Huang, S.3
Ding, J.4
Tan, N.5
Zhao, Y.6
Yan, M.7
Ge, C.8
Zhang, Z.9
Chen, T.10
Wan, D.11
Yao, M.12
Li, J.13
Gu, J.14
He, X.15
-
92
-
-
77950516941
-
Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA
-
Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, Wang H, Gu J, Yao M, Li J, Tu H, He X. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 2010; 12: 390-399.
-
(2010)
Nat Cell Biol
, vol.12
, pp. 390-399
-
-
Ding, J.1
Huang, S.2
Wu, S.3
Zhao, Y.4
Liang, L.5
Yan, M.6
Ge, C.7
Yao, J.8
Chen, T.9
Wan, D.10
Wang, H.11
Gu, J.12
Yao, M.13
Li, J.14
Tu, H.15
He, X.16
-
93
-
-
77956640400
-
MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma
-
Luedde T. MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma. Hepatology 2010; 52: 1164-1166.
-
(2010)
Hepatology
, vol.52
, pp. 1164-1166
-
-
Luedde, T.1
-
94
-
-
84857052156
-
Upregulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation
-
Han ZB, Chen HY, Fan JW, Wu JY, Tang HM, Peng ZH. Upregulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. J Cancer Res Clin Oncol 2012; 138: 153-161.
-
(2012)
J Cancer Res Clin Oncol
, vol.138
, pp. 153-161
-
-
Han, Z.B.1
Chen, H.Y.2
Fan, J.W.3
Wu, J.Y.4
Tang, H.M.5
Peng, Z.H.6
-
95
-
-
84857981395
-
Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma
-
Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang Y, Zhao J, McCrae MA, Zhuang H. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer 2012; 118: 2431-42.
-
(2012)
Cancer
, vol.118
, pp. 2431-2442
-
-
Xie, Q.1
Chen, X.2
Lu, F.3
Zhang, T.4
Hao, M.5
Wang, Y.6
Zhao, J.7
McCrae, M.A.8
Zhuang, H.9
-
96
-
-
52949127316
-
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
-
Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008; 27: 5651-5661.
-
(2008)
Oncogene
, vol.27
, pp. 5651-5661
-
-
Fornari, F.1
Gramantieri, L.2
Ferracin, M.3
Veronese, A.4
Sabbioni, S.5
Calin, G.A.6
Grazi, G.L.7
Giovannini, C.8
Croce, C.M.9
Bolondi, L.10
Negrini, M.11
-
97
-
-
69349083676
-
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality
-
Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini M. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 2009; 15: 5073-5081.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5073-5081
-
-
Gramantieri, L.1
Fornari, F.2
Ferracin, M.3
Veronese, A.4
Sabbioni, S.5
Calin, G.A.6
Grazi, G.L.7
Croce, C.M.8
Bolondi, L.9
Negrini, M.10
-
98
-
-
70949104622
-
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
-
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, Croce CM. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009; 16: 498-509.
-
(2009)
Cancer Cell
, vol.16
, pp. 498-509
-
-
Garofalo, M.1
Di Leva, G.2
Romano, G.3
Nuovo, G.4
Suh, S.S.5
Ngankeu, A.6
Taccioli, C.7
Pichiorri, F.8
Alder, H.9
Secchiero, P.10
Gasparini, P.11
Gonelli, A.12
Costinean, S.13
Acunzo, M.14
Condorelli, G.15
Croce, C.M.16
-
99
-
-
38949184246
-
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
-
Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14: 419-427.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 419-427
-
-
Jiang, J.1
Gusev, Y.2
Aderca, I.3
Mettler, T.A.4
Nagorney, D.M.5
Brackett, D.J.6
Roberts, L.R.7
Schmittgen, T.D.8
-
100
-
-
34447117003
-
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma
-
Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67: 6092-6099.
-
(2007)
Cancer Res
, vol.67
, pp. 6092-6099
-
-
Gramantieri, L.1
Ferracin, M.2
Fornari, F.3
Veronese, A.4
Sabbioni, S.5
Liu, C.G.6
Calin, G.A.7
Giovannini, C.8
Ferrazzi, E.9
Grazi, G.L.10
Croce, C.M.11
Bolondi, L.12
Negrini, M.13
-
101
-
-
78649561463
-
Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A)
-
Lan FF, Wang H, Chen YC, Chan CY, Ng SS, Li K, Xie D, He ML, Lin MC, Kung HF. Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int J Cancer 2011; 128: 319-331.
-
(2011)
Int J Cancer
, vol.128
, pp. 319-331
-
-
Lan, F.F.1
Wang, H.2
Chen, Y.C.3
Chan, C.Y.4
Ng, S.S.5
Li, K.6
Xie, D.7
He, M.L.8
Lin, M.C.9
Kung, H.F.10
-
102
-
-
77951620660
-
The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma
-
Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, Hosui A, Tatsumi T, Ishida H, Noda T, Nagano H, Doki Y, Mori M, Hayashi N. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010; 52: 698-704.
-
(2010)
J Hepatol
, vol.52
, pp. 698-704
-
-
Shimizu, S.1
Takehara, T.2
Hikita, H.3
Kodama, T.4
Miyagi, T.5
Hosui, A.6
Tatsumi, T.7
Ishida, H.8
Noda, T.9
Nagano, H.10
Doki, Y.11
Mori, M.12
Hayashi, N.13
-
103
-
-
34250163202
-
Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation
-
Shah YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez FJ. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol Cell Biol 2007; 27: 4238-4247.
-
(2007)
Mol Cell Biol
, vol.27
, pp. 4238-4247
-
-
Shah, Y.M.1
Morimura, K.2
Yang, Q.3
Tanabe, T.4
Takagi, M.5
Gonzalez, F.J.6
-
104
-
-
48549091046
-
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis
-
Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008; 68: 5049-5058.
-
(2008)
Cancer Res
, vol.68
, pp. 5049-5058
-
-
Datta, J.1
Kutay, H.2
Nasser, M.W.3
Nuovo, G.J.4
Wang, B.5
Majumder, S.6
Liu, C.G.7
Volinia, S.8
Croce, C.M.9
Schmittgen, T.D.10
Ghoshal, K.11
Jacob, S.T.12
-
105
-
-
66449136951
-
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
-
Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-1017.
-
(2009)
Cell
, vol.137
, pp. 1005-1017
-
-
Kota, J.1
Chivukula, R.R.2
O'Donnell, K.A.3
Wentzel, E.A.4
Montgomery, C.L.5
Hwang, H.W.6
Chang, T.C.7
Vivekanandan, P.8
Torbenson, M.9
Clark, K.R.10
Mendell, J.R.11
Mendell, J.T.12
-
106
-
-
77950602604
-
Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma
-
Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010; 51: 836-845.
-
(2010)
Hepatology
, vol.51
, pp. 836-845
-
-
Xiong, Y.1
Fang, J.H.2
Yun, J.P.3
Yang, J.4
Zhang, Y.5
Jia, W.H.6
Zhuang, S.M.7
-
107
-
-
59149098054
-
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity
-
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009; 69: 1135-1142.
-
(2009)
Cancer Res
, vol.69
, pp. 1135-1142
-
-
Su, H.1
Yang, J.R.2
Xu, T.3
Huang, J.4
Xu, L.5
Yuan, Y.6
Zhuang, S.M.7
-
108
-
-
34250851115
-
A microRNA component of the p53 tumour suppressor network
-
He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134.
-
(2007)
Nature
, vol.447
, pp. 1130-1134
-
-
He, L.1
He, X.2
Lim, L.P.3
de Stanchina, E.4
Xuan, Z.5
Liang, Y.6
Xue, W.7
Zender, L.8
Magnus, J.9
Ridzon, D.10
Jackson, A.L.11
Linsley, P.S.12
Chen, C.13
Lowe, S.W.14
Cleary, M.A.15
Hannon, G.J.16
-
109
-
-
58549114916
-
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
-
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 2009; 275: 44-53.
-
(2009)
Cancer Lett
, vol.275
, pp. 44-53
-
-
Li, N.1
Fu, H.2
Tie, Y.3
Hu, Z.4
Kong, W.5
Wu, Y.6
Zheng, X.7
-
110
-
-
49749150980
-
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
-
Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM, Maris JM. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 2008; 6: 735-742.
-
(2008)
Mol Cancer Res
, vol.6
, pp. 735-742
-
-
Cole, K.A.1
Attiyeh, E.F.2
Mosse, Y.P.3
Laquaglia, M.J.4
Diskin, S.J.5
Brodeur, G.M.6
Maris, J.M.7
-
111
-
-
65449170725
-
MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma
-
Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J, Sun Z, Wei L, Zheng X. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 2009; 49: 1194-1202.
-
(2009)
Hepatology
, vol.49
, pp. 1194-1202
-
-
Li, S.1
Fu, H.2
Wang, Y.3
Tie, Y.4
Xing, R.5
Zhu, J.6
Sun, Z.7
Wei, L.8
Zheng, X.9
-
112
-
-
77956553611
-
Therapeutics Based on microRNA: A New Approach for Liver Cancer
-
Zhang G, Wang Q, Xu R. Therapeutics Based on microRNA: A New Approach for Liver Cancer. Curr Genomics 2010; 11: 311-325.
-
(2010)
Curr Genomics
, vol.11
, pp. 311-325
-
-
Zhang, G.1
Wang, Q.2
Xu, R.3
-
113
-
-
79960469058
-
FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway
-
Kottakis F, Polytarchou C, Foltopoulou P, Sanidas I, Kampranis SC, Tsichlis PN. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol Cell 2011; 43: 285-298.
-
(2011)
Mol Cell
, vol.43
, pp. 285-298
-
-
Kottakis, F.1
Polytarchou, C.2
Foltopoulou, P.3
Sanidas, I.4
Kampranis, S.C.5
Tsichlis, P.N.6
-
114
-
-
79952114916
-
The liver-specific microRNA miR-122: Biology and therapeutic potential
-
Filipowicz W, Grosshans H. The liver-specific microRNA miR-122: biology and therapeutic potential. Prog Drug Res 2011; 67: 221-238.
-
(2011)
Prog Drug Res
, vol.67
, pp. 221-238
-
-
Filipowicz, W.1
Grosshans, H.2
-
115
-
-
50849115468
-
miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines
-
Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2008; 375: 315-320.
-
(2008)
Biochem Biophys Res Commun
, vol.375
, pp. 315-320
-
-
Lin, C.J.1
Gong, H.Y.2
Tseng, H.C.3
Wang, W.L.4
Wu, J.L.5
-
116
-
-
77952299722
-
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
-
Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31:766-776.
-
(2010)
Carcinogenesis
, vol.31
, pp. 766-776
-
-
Furuta, M.1
Kozaki, K.I.2
Tanaka, S.3
Arii, S.4
Imoto, I.5
Inazawa, J.6
-
117
-
-
84855191863
-
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
-
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, Kung HF, Xie D. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 2012; 61: 278-289.
-
(2012)
Gut
, vol.61
, pp. 278-289
-
-
Zheng, F.1
Liao, Y.J.2
Cai, M.Y.3
Liu, Y.H.4
Liu, T.H.5
Chen, S.P.6
Bian, X.W.7
Guan, X.Y.8
Lin, M.C.9
Zeng, Y.X.10
Kung, H.F.11
Xie, D.12
-
118
-
-
50549084147
-
Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma
-
Li W, Xie L, He X, Li J, Tu K, Wei L, Wu J, Guo Y, Ma X, Zhang P, Pan Z, Hu X, Zhao Y, Xie H, Jiang G, Chen T, Wang J, Zheng S, Cheng J, Wan D, Yang S, Li Y, Gu J. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008; 123: 1616-1622.
-
(2008)
Int J Cancer
, vol.123
, pp. 1616-1622
-
-
Li, W.1
Xie, L.2
He, X.3
Li, J.4
Tu, K.5
Wei, L.6
Wu, J.7
Guo, Y.8
Ma, X.9
Zhang, P.10
Pan, Z.11
Hu, X.12
Zhao, Y.13
Xie, H.14
Jiang, G.15
Chen, T.16
Wang, J.17
Zheng, S.18
Cheng, J.19
Wan, D.20
Yang, S.21
Li, Y.22
Gu, J.23
more..
-
119
-
-
64349101658
-
MicroRNA-125b is a novel negative regulator of p53
-
Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V, Lodish HF, Lim B. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 2009; 23: 862-876.
-
(2009)
Genes Dev
, vol.23
, pp. 862-876
-
-
Le, M.T.1
Teh, C.2
Shyh-Chang, N.3
Xie, H.4
Zhou, B.5
Korzh, V.6
Lodish, H.F.7
Lim, B.8
-
120
-
-
67651154718
-
MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells
-
Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, Zhuang SM. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 2009; 50: 113-121.
-
(2009)
Hepatology
, vol.50
, pp. 113-121
-
-
Xu, T.1
Zhu, Y.2
Xiong, Y.3
Ge, Y.Y.4
Yun, J.P.5
Zhuang, S.M.6
-
121
-
-
84855578117
-
Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma
-
Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma. Cell Biochem Biophys 2012; 62: 237-244.
-
(2012)
Cell Biochem Biophys
, vol.62
, pp. 237-244
-
-
Jia, X.Q.1
Cheng, H.Q.2
Qian, X.3
Bian, C.X.4
Shi, Z.M.5
Zhang, J.P.6
Jiang, B.H.7
Feng, Z.Q.8
-
122
-
-
46249125127
-
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1
-
Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 2008; 135: 257-269.
-
(2008)
Gastroenterology
, vol.135
, pp. 257-269
-
-
Wong, Q.W.1
Lung, R.W.2
Law, P.T.3
Lai, P.B.4
Chan, K.Y.5
To, K.F.6
Wong, N.7
-
123
-
-
77950626836
-
MicroRNA-375 targets Hipposignaling effector YAP in liver cancer and inhibits tumor properties
-
Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hipposignaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 2010; 394: 623-627.
-
(2010)
Biochem Biophys Res Commun
, vol.394
, pp. 623-627
-
-
Liu, A.M.1
Poon, R.T.2
Luk, J.M.3
-
124
-
-
84863804699
-
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
-
He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin J S. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012; 31: 3357-69.
-
(2012)
Oncogene
, vol.31
, pp. 3357-3369
-
-
He, X.X.1
Chang, Y.2
Meng, F.Y.3
Wang, M.Y.4
Xie, Q.H.5
Tang, F.6
Li, P.Y.7
Song, Y.H.8
Lin, J.S.9
-
125
-
-
0032742183
-
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
-
Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440.
-
(1999)
Hepatology
, vol.30
, pp. 1434-1440
-
-
Llovet, J.M.1
Fuster, J.2
Bruix, J.3
-
126
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
-
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
-
(1996)
N Engl J Med
, vol.334
, pp. 693-699
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
Andreola, S.4
Pulvirenti, A.5
Bozzetti, F.6
Montalto, F.7
Ammatuna, M.8
Morabito, A.9
Gennari, L.10
-
127
-
-
61949290827
-
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies
-
Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49: 453-459.
-
(2009)
Hepatology
, vol.49
, pp. 453-459
-
-
Cho, Y.K.1
Kim, J.K.2
Kim, M.Y.3
Rhim, H.4
Han, J.K.5
-
128
-
-
7044229703
-
Chemoembolization for hepatocellular carcinoma
-
Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004; 127: S179-188.
-
(2004)
Gastroenterology
, vol.127
-
-
Bruix, J.1
Sala, M.2
Llovet, J.M.3
-
129
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
de Oliveira, A.C.7
Santoro, A.8
Raoul, J.L.9
Forner, A.10
Schwartz, M.11
Porta, C.12
Zeuzem, S.13
Bolondi, L.14
Greten, T.F.15
Galle, P.R.16
Seitz, J.F.17
Borbath, I.18
Haussinger, D.19
Giannaris, T.20
Shan, M.21
Moscovici, M.22
Voliotis, D.23
Bruix, J.24
more..
-
130
-
-
40249104566
-
The utility of LNA in microRNA-based cancer diagnostics and therapeutics
-
Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin Cancer Biol 2008; 18: 89-102.
-
(2008)
Semin Cancer Biol
, vol.18
, pp. 89-102
-
-
Stenvang, J.1
Silahtaroglu, A.N.2
Lindow, M.3
Elmen, J.4
Kauppinen, S.5
-
131
-
-
79953202455
-
Silencing of microRNA families by seed-targeting tiny LNAs
-
Obad S, dos Santos CO, Petri A, Heidenblad M, Broom O, Ruse C, Fu C, Lindow M, Stenvang J, Straarup EM, Hansen HF, Koch T, Pappin D, Hannon GJ, Kauppinen S. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 2011; 43: 371-378.
-
(2011)
Nat Genet
, vol.43
, pp. 371-378
-
-
Obad, S.1
dos Santos, C.O.2
Petri, A.3
Heidenblad, M.4
Broom, O.5
Ruse, C.6
Fu, C.7
Lindow, M.8
Stenvang, J.9
Straarup, E.M.10
Hansen, H.F.11
Koch, T.12
Pappin, D.13
Hannon, G.J.14
Kauppinen, S.15
-
132
-
-
84255192032
-
miR-221 silencing blocks hepatocellular carcinoma and promotes survival
-
Park JK, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T, Schmittgen TD. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res 2011; 71: 7608-7616.
-
(2011)
Cancer Res
, vol.71
, pp. 7608-7616
-
-
Park, J.K.1
Kogure, T.2
Nuovo, G.J.3
Jiang, J.4
He, L.5
Kim, J.H.6
Phelps, M.A.7
Papenfuss, T.L.8
Croce, C.M.9
Patel, T.10
Schmittgen, T.D.11
-
133
-
-
0037333815
-
Genetic fate of recombinant adeno-associated virus vector genomes in muscle
-
Schnepp BC, Clark KR, Klemanski DL, Pacak CA, Johnson PR. Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J Virol 2003; 77: 3495-3504.
-
(2003)
J Virol
, vol.77
, pp. 3495-3504
-
-
Schnepp, B.C.1
Clark, K.R.2
Klemanski, D.L.3
Pacak, C.A.4
Johnson, P.R.5
-
134
-
-
0037015049
-
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
-
Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci U S A 2002; 99: 11854-11859.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 11854-11859
-
-
Gao, G.P.1
Alvira, M.R.2
Wang, L.3
Calcedo, R.4
Johnston, J.5
Wilson, J.M.6
-
135
-
-
54849162100
-
Self-complementary AAV vectors; advances and applications
-
McCarty DM. Self-complementary AAV vectors; advances and applications. Mol Ther 2008; 16: 1648-1656.
-
(2008)
Mol Ther
, vol.16
, pp. 1648-1656
-
-
McCarty, D.M.1
-
136
-
-
80051590849
-
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice
-
Pramanik D, Campbell NR, Karikari C, Chivukula R, Kent OA, Mendell JT, Maitra A. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol Cancer Ther 2011; 10: 1470-1480.
-
(2011)
Mol Cancer Ther
, vol.10
, pp. 1470-1480
-
-
Pramanik, D.1
Campbell, N.R.2
Karikari, C.3
Chivukula, R.4
Kent, O.A.5
Mendell, J.T.6
Maitra, A.7
-
137
-
-
24644483623
-
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA
-
Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-1581.
-
(2005)
Science
, vol.309
, pp. 1577-1581
-
-
Jopling, C.L.1
Yi, M.2
Lancaster, A.M.3
Lemon, S.M.4
Sarnow, P.5
-
138
-
-
42249093319
-
LNA-mediated microRNA silencing in non-human primates
-
Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452: 896-899.
-
(2008)
Nature
, vol.452
, pp. 896-899
-
-
Elmen, J.1
Lindow, M.2
Schutz, S.3
Lawrence, M.4
Petri, A.5
Obad, S.6
Lindholm, M.7
Hedtjarn, M.8
Hansen, H.F.9
Berger, U.10
Gullans, S.11
Kearney, P.12
Sarnow, P.13
Straarup, E.M.14
Kauppinen, S.15
-
139
-
-
74249112787
-
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
-
Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.
-
(2010)
Science
, vol.327
, pp. 198-201
-
-
Lanford, R.E.1
Hildebrandt-Eriksen, E.S.2
Petri, A.3
Persson, R.4
Lindow, M.5
Munk, M.E.6
Kauppinen, S.7
Orum, H.8
|